New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
Limiting Noninvasive Prenatal Testing
A new report on noninvasive prenatal testing (NIPT) by the UK's Nuffield Council on Bioethics expresses concerns about the way the test is being sold by private providers. In addition, the Council calls for better information and support, a moratorium on the use of NIPT in sequencing the whole genome of fetuses and a ban on its use in finding out the sex of the fetus.
The Council considered, at this early stage of its use, how NIPT could change the way we view pregnancy, disability, and difference, and what the wider consequences of its increasing use might be. The report recommends that NIPT should only be used for significant medical conditions and impairments that affect the child at birth or in early life, as this information can allow women and couples to make meaningful reproductive choices.